Inside Precision Medicine·4 min read·hard
Genetic Variants Linked to CAR T-Cell Efficacy and Safety
C
Clara Rodriguez Fernandez
✦AI Summary
Researchers have identified specific genetic variants that influence the efficacy and toxicity of CAR T-cell therapy in lymphoma patients. These findings suggest that a patient's unique genetic makeup plays a critical role in how they respond to personalized cancer immunotherapies.
Scientists have identified variants in three genes that influence both the efficacy of CAR T-cell therapy and the likelihood of severe side effects. Published today in Science Immunology , these findings represent a first step toward adopting a precision medicine approach in an increasingly used form of cancer immunotherapy.
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in